WITHDRAWN: A recent perspective on the potential of grid-connected renewable energy systems including optimal design for the pharmaceutical industry of North Indian Himalayan, India

Author:

Gupta Ankush1,Suhag Prof. Sathans1

Affiliation:

1. National Institute of Technology

Abstract

Abstract

The objective of the research is to assess the techno-economic potential of a structure designed to meet the energy requirements of the Indian pharmaceutical industry (PMI) for the North Indian Himalayan (NIH) region, India, and the same structure is implemented for one site in each state and each union territory of the NIH. Besides, several grid-connected and off-grid hybrid renewable energy system (RES) configurations are evaluated using the HOMER software for the sake to figure out which configuration has the most technical and economic potential. Grid-WECS-PV has been found to be the optimal configuration for each NIH site, and it has been recognised that hybrid RESs have a substantial impact on the economic aspect, the cost of electricity (COE) of this configuration for the sites in Solan, Samba, Kargil, and Jadhang is lower than their respective grid tariff, and the difference between COE and the corresponding grid tariff varies based on the climate of site. As therefore, this investigation explores the potential to develop dynamic behaviour for energy utilization for PMI building in NIH, India, with a decline in overall manufacturing costs, which also adheres to the target of "Promotion of Bulk Drug Parks" that has been announced by the Indian government and promotes hybrid industrialization.

Publisher

Springer Science and Business Media LLC

Reference42 articles.

1. The contribution of intellectual capital to financial stability in Indian pharmaceutical companies;Festa G;J Intellect Capital,2021

2. Pharmaceutical Market Structure in India & Competition Concerns;Chitra M;Shanlax Int J Arts Sci Humanit,2020

3. Indian pharmaceuticals industry, https://www.ibef.org

4. Department of Pharmaceuticals annual report 2021-22, Government of India Ministry of Chemicals & Fertilizers, https://pharmaceuticals.gov.in

5. Indian pharmaceutical - a formula for success, https://www.linkedin.com/in/sharma-gagan

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3